Press Releases

ProPharma Announces the Appointment of Dr. Ronald Freeze, Ph.D., as Global Head of Medical Technology

RALEIGH, NC, May 17, 2023, ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry, and a portfolio company of Odyssey...

Multiple mobile devices with analytical data

ProPharma Announces Strategic Partnership with H1 to Optimize R&D with AI, Data Insights and Analytics

RALEIGH, NC, May 9, 2023, ProPharma Group (ProPharma), the world’s largest Research Consulting Organization (RCO) and a portfolio company of Odyssey Investment Partners, and H1, a leading healthcare...

View of ProPharma's new Headquarters in Raleigh, NC.

ProPharma Announces New Global Headquarters in Raleigh, NC as Hub for Innovation and Talent

RALEIGH, NC, April 3, 2023: ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry and a portfolio company of Odyssey...

Hands working on a laptop

ProPharma Group Announces Acquisition of Kateric, An Industry-Leading Medical Writing Company

Chicago, IL, September 1, 2022 -- ProPharma Group (PPG), the leading global provider of regulatory, clinical and quality services for the life sciences industry, announces the acquisition of Kateric...

Professionals collaborating at a table.

ProPharma Group Acquires OneSource Regulatory to Bolster its Regulatory Consultancy Services

Chicago, IL, August 23, 2022 -- ProPharma Group (PPG), the leading global provider of regulatory, clinical, quality and compliance, medical information, and pharmacovigilance services and solutions...

Mydecine Innovations Group Engages ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials

DENVER, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research,...

ProPharma Group Announces New President / CEO

ProPharma Group announced today that Dawn Sherman has been named President and CEO, effective May 14, 2018. A veteran in leading healthcare-focused businesses, Dawn brings extensive international...

ProPharma Group Launches New Branding

Today ProPharma Group is proud to announce the launch of our new company brand identity, which includes an innovative new logo, tagline, colors, and as you can see, a new website. Our business has...